Open access · US-GOV via ClinicalTrials.gov Clinical trial

Amyloid Imaging With 11C-PiB in Healthy Aging and Mild Cognitive Impairment

Authors not listed

University of Colorado, Denver · 2016

Loss of proteostasis Human Randomized controlled trial

Abstract

The purpose of this study is to measure the amount of amyloid in the brain. Amyloid is a protein found in the brain of patients with Alzheimer's disease and can be detected using a Positron Emission Tomography (PET) scan. This study is interested in how amyloid levels in the brain relate to memory and thinking abilities.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-16 MST

Cite this

APA

Anonymous. (2016). Amyloid Imaging With 11C-PiB in Healthy Aging and Mild Cognitive Impairment. <em>University of Colorado, Denver</em>. https://clinicaltrials.gov/study/NCT04505735

Vancouver

Anonymous. Amyloid Imaging With 11C-PiB in Healthy Aging and Mild Cognitive Impairment. University of Colorado, Denver. 2016.

BibTeX

@misc{anon2016Amyloi, title = {Amyloid Imaging With 11C-PiB in Healthy Aging and Mild Cognitive Impairment}, author = {Anonymous}, journal = {University of Colorado, Denver}, year = {2016}, }